CYD-2-88

• Description :

  CYD-2-88 (BDA-366 analog) is a BDA-366 (HY-101083) (Bcl2 BH4 antagonist) analog. CYD-2-88 (20 mg/kg, i.p.) inhibits tumor growth in NSCLC H460 xenografts mice[1].

• Product Name Alternative :

  BDA-366 analog

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H315-H319-H335

• Target :

  Bcl-2 Family

• Type :

  Reference compound

• Related Pathways :

  Apoptosis

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/cyd-2-88.html

• Smiles :

  O[C@@H](CNC1=CC=C(C2=C1C(C3=C(C=CC=C3)C2=O)=O)NC[C@@H]4OC4)CN5CCCCC5

• Molecular Formula :

  C25H29N3O4

• Molecular Weight :

  435.52

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Xingming DENG, et al. Bh4 antagonists and methods related thereto. Patent. WO2015171589.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1821496-27-8]